Replies to post #132692 on Biotech Values

[DewDiligence]

I never liked that company and was surprised when Eric Rowinsky, ex-CMO of ImClone, became a BoD member and a Lymphoseek cheerleader.

[DewDiligence]

Navidea (NEOP) licenses Alzheimer’s imaging agent from AZN:

http://finance.yahoo.com/news/Neoprobe-Licenses-AstraZeneca-bw-929146885.html?x=0

Financial terms of the in-licensing agreement include an upfront payment of $5 million to AstraZeneca and a series of contingent milestone payments including up to $6.5 million in potential payments based on the achievement of clinical development and regulatory filing milestones and up to additional $11 million due following the receipt of regulatory approvals and the initiation of commercial sales.

LOL—this product is not going to be a blockbuster, evidently.